Frontpage Hero

Because we care, we need to act

Sobi 2018 Annual and Sustainability Report

Sobi 2018 Annual and Sustainability Report - now published

"2018 was a year of transformation for Sobi,” says Guido Oelkers, CEO and President. “Our substantial progress in Haemophilia, acquisitions in Immunology and sales growth in Specialty Care mean that the company is essentially, on a pro-forma basis, two-and-a-half times the size it was at the end of 2016. But it is important to understand that we see this as an important stepping stone. In the Annual and Sustainability Report, we outline how the strong growth we delivered throughout 2018 is fuelling our vision of becoming global leaders in providing innovative treatments that transform life for people with rare diseases".
Sobi Capital Markets Day

Sobi Capital Markets Day - 14 May

An opportunity for institutional investors, analysts and media to learn more about Sobi, our therapeutic areas and future growth strategy as well our financial performance.
Sobi Annual General Meeting

Annual General Meeting 2019

The Annual General Meeting (“AGM”) in Swedish Orphan Biovitrum AB (publ) will be held on Thursday, May 9 at 3.00 p.m. at Grand Hôtel, S. Blasieholmshamnen 8, Stockholm, Sweden.

Press releases

Swedish Orphan Biovitrum AB (publ) (Sobi™) has released the company’s 2018 Annual and Sustainability Report. The integrated report summarises our business and strategy, financial performance and work on sustainability.

“2018 was a year of transformation for Sobi,” says...

04/18/2019 - 10:00

To mark World Haemophilia Day, Sobi™ is launching Liberate Life™, a vision of living life beyond haemophilia. In a series of long-term commitments, Sobi seeks to shape new standards, optimise treatment, build evidence, create sustainable access and provide community...

04/17/2019 - 08:00

On 25 April, at 08:00 CET, Swedish Orphan Biovitrum AB (publ) (Sobi™) will publish its report for the first quarter 2019. Financial analysts and media are invited to participate in a telephone conference, which will include a presentation of the results, on the same day...

04/12/2019 - 10:00

The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi™) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the “Meeting”), to be held on Thursday, 9 May 2019 at 15:00 at Grand Hôtel, Södra Blasieholmshamnen 8, Stockholm, Sweden.


04/03/2019 - 09:30
Contact us

Sobi Head Office
+46 8 697 20 00
Tomtebodavägen 23A
SE-112 76 Stockholm, Sweden